Product Reports Resources Pricing Login Book a demo

UltraSight

Health Tech & Medtech · Rehovot, Israel · Founded 2018

Real-time guidance and quality assessment to allow healthcare professionals to consistently perform high-quality cardiac ultrasound in a variety of settings MoreLess

UltraSight is a pioneering company in the medical technology sector, focusing on revolutionizing cardiac ultrasound through advanced machine learning. The company's core product is an AI-guided ultrasound system that aids healthcare professionals in making more accurate and timely clinical decisions. UltraSight's technology is designed to be used in various care settings, from doctors' offices and community hospitals to ambulances and remote communities, thereby increasing patient access to high-quality cardiac imaging. The business primarily serves healthcare providers, including hospitals, clinics, and emergency medical services, operating within the global healthcare market. UltraSight's business model involves selling its AI-guided ultrasound systems and software subscriptions to medical institutions. The company generates revenue through direct sales, partnerships, and collaborations with major healthcare providers and technology companies, such as GE Healthcare. By leveraging machine learning and AI, UltraSight aims to democratize access to advanced cardiac care, making it more widely available and improving patient outcomes.

Keywords: AI-guided ultrasound, cardiac imaging, machine learning, healthcare technology, point-of-care, clinical decisions, medical devices, remote diagnostics, healthcare access, advanced imaging.

Company overview

UltraSight company information

The essential company record, classifications and operating signals in one place.

Status
Operational
Founded
2018
Headquarters
Rehovot, Israel
Employees
42
Open positions
None listed
Dealroom signal
76.8
client focusb2btechnologyArtificial IntelligencetechnologyDeep Techsub industryHealth Platformbusiness modelSaaSindustryHealthsectorCardiology and cardiovascularsectorSpinoutsectorTech for Hospitals and ClinicssectorTech for Medical ProfessionalssectorAI for medical imagingsectorPhysician Support ToolssectorHard TechsectorDT and LS

Valuation & funding

UltraSight funding history

Company financing events and reported valuations.

Deal typeDateAmountValuationInvestorsSource
LATE VCEquity / VC Jun 2023 $0 SELVAS Healthcare (Formerly Hana Must Second Special Purpose Acquisition Company)
SPINOUTOther financing Aug 2022 $0 Weizmann Institute of Science
SERIES BEquity / VC May 2021 $13M $52M Yozma Group · Atain specialty insurance company · Weizmann Institute of Science
SERIES AEquity / VC Mar 2019 $2M $8M Yozma Group
Showing 4 recorded eventsUnlock the complete deal history →

Financials

Revenue and workforce over time

Available revenue and workforce history. Fields without reported data are omitted.

YearRevenueGrowthEmployees
2026 $2.9M 0% 42
2025 $2.9M 0% 39
2024 $2.9M 0% 34
2023 $2.9M +26.1% 29
2022 $2.3M +135.9% 26
2021 $975K 13
Company filings, research estimates and Dealroom dataOpen the full financial model →

Growth signals

UltraSight website traffic

Latest recorded traffic for UltraSight is 1.8K monthly website visits, up 63.6% over the last three months. UltraSight's team grew 7.7% over the past year.

Latest monthly visits1.8K 3-month web change+63.6% 1-year team growth+7.7%
Monthly website visits41 observations · Dec 2022–Jul 2026
Hover or focus a point to see its exact monthly valueCompare with peers →

Comparisons

UltraSight compared with similar companies

Dealroom’s weighted taxonomy model identifies the closest operating peers. Company identity and context stay open; selected comparison metrics preview what is available in the platform.

Showing 8 of the closest matchesCompare every metric →

Talent graph

UltraSight's talent

Book a demo to see the people
Team profiled 7 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 3 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Investors

4 investors on UltraSight's cap table

Sourced from Dealroom's funding and investor records.

Series A 3 investors entered at this stage
Yozma Group
Atain specialty insurance company
Weizmann Institute of Science
Series B+ 1 investor entered at this stage
SELVAS Healthcare (Formerly Hana Must Second Special Purpose Acquisition Company)

Global footprint

Where UltraSight has talent and traffic

Workforce by country
3 countries with
team presence
🇺🇸 United States31.3%
🇮🇱 Israel31.3%
🇨🇦 Canada6.3%
3 countries shown

In the news

Latest news about UltraSight

Recent press, funding announcements, and product moves mentioning UltraSight — open to read from the original sources.

See all news

Market sentiment

What the market is saying about UltraSight

An AI-synthesized read of the highest-engagement posts about UltraSight on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See UltraSight’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Takes under a minute. Already use Dealroom? Log in.